|
Volumn 35, Issue 1, 2003, Pages 172-173
|
The relevance of nonmyeloablative transplants in developing countries: Lessons from the UK experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
ANTIVIRUS AGENT;
CYCLOSPORIN;
FLUDARABINE;
MELPHALAN;
ALLOGENIC BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
CYTOMEGALOVIRUS INFECTION;
DEVELOPING COUNTRY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
GRAFT INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
GRAFT VERSUS HOST REACTION;
HLA MATCHING;
HUMAN;
MORTALITY;
PRIORITY JOURNAL;
TREATMENT INDICATION;
UNITED KINGDOM;
|
EID: 0037319066
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03870-8 Document Type: Conference Paper |
Times cited : (2)
|
References (7)
|